Cannabis4MSinBC wrote:Since cannabis acts as a nervous system regulator, slowing down nerve impulses, it makes sense that it could possibly slow down the actions of those immune system antibodies that are responsible for the demyelination for nerve insulation.
If marijuana were discovered in some rainforest tomorrow, it would be touted as the next wonder drug. But because a bunch of dirty hippies smoke it while dancing to a Fish concert, it's evil.
NHE wrote:Cannabis4MSinBC wrote:Since cannabis acts as a nervous system regulator, slowing down nerve impulses, it makes sense that it could possibly slow down the actions of those immune system antibodies that are responsible for the demyelination for nerve insulation.
I'm not seeing a connection between the two unless mj suppresses the immune system in some way.
Physorg.com wrote:Cannabis works because it stimulates molecules known as cannabinoid receptors within the body. The group had previously reported that THC could alleviate disease symptoms, and also save nerves from the damaging effects of the disease - thus potentially, via the cannabinoid receptor CB1, slowing down the development of progressive disability. They had not previously examined the influence of cannabinoids on immune aspects of the disease.
Now their most recent study has successfully separated the roles of cannabinoid receptors CB1 and CB2 on neurons and T cells, and investigated their effect in controlling central nervous system autoimmunity. It showed that CB1 receptor expression by nerves in the brain, but not T cells, could suppress the development of an experimental MS-like disease, by stimulating the release of anti-inflammatory molecules, whilst in contrast direct stimulation of CB2 receptors by T cells was also able to control inflammation associated with the condition. This suggests that cannabis-like drugs may have the potential to block the autoimmune response which drives disease development.
Professor David Baker said: “Whilst targeting CB1 receptors for therapy runs the risk of causing the unwanted “high” to achieve these effects, we can get the same result by targeting CB2 receptors, which avoids these risks. Therefore, we can start to think about using new drugs that harness the potential medical benefits that cannabis has to offer but move away from the issues over the legality and recreational use of the plant product”.
Users browsing this forum: No registered users